Logan Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Logan Capital Management's BMY Position: Q2 2026 in Review
Logan Capital Management opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 19,447 shares worth $1.12M. The stake represents 0.04% of the portfolio and ranks #209 among its holdings. This is a return to the name: Logan Capital Management previously reported a position in BMY as recently as Q4 2025.
Logan Capital Management first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.67M in Q4 2022. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Logan Capital Management held 19,447 shares of Bristol-Myers Squibb worth $1.12M as of Q2 2026.
- Bristol-Myers Squibb was a new Logan Capital Management position in Q2 2026.
- Bristol-Myers Squibb made up 0.04% of Logan Capital Management's portfolio in Q2 2026, its #209 holding.
- Logan Capital Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Logan Capital Management's Bristol-Myers Squibb position peaked at $3.67M in Q4 2022.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Logan Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.